Information:
Fel:
ID
23147
Beskrivning
Clinical Trial of Recombinant Hepatitis E Vaccine; ODM derived from: https://clinicaltrials.gov/show/NCT01014845
Länk
https://clinicaltrials.gov/show/NCT01014845
Nyckelord
Versioner (1)
- 2017-06-26 2017-06-26 -
Uppladdad den
26 juni 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis E NCT01014845
Eligibility Hepatitis E NCT01014845
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis E NCT01014845
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
healthy people aged from 16 years to 65 years old at the time of the first vaccination, normal intelligence and agree to sign the informed consent form.
boolean
C0001779 (UMLS CUI [1,1])
C0424576 (UMLS CUI [1,2])
C1168057 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,4])
C0424576 (UMLS CUI [1,2])
C1168057 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,4])
ID.2
Item
subjects will reside in the study region in the next 19 months.
boolean
C1550511 (UMLS CUI [1])
ID.3
Item
free of history of hepatitis b or hepatitis e.
boolean
C0332122 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0085293 (UMLS CUI [1,3])
C0019163 (UMLS CUI [1,2])
C0085293 (UMLS CUI [1,3])
ID.4
Item
can comply with the request of study.
boolean
C1321605 (UMLS CUI [1])
ID.5
Item
axillary temperature is below 37 degree centigrade.
boolean
C1531924 (UMLS CUI [1])
ID.7
Item
having other vaccine or immunoglobulin within two weeks;
boolean
C0042196 (UMLS CUI [1,1])
C0021027 (UMLS CUI [1,2])
C0021027 (UMLS CUI [1,2])
ID.8
Item
having allergic history to vaccine and medicine
boolean
C0571550 (UMLS CUI [1])
ID.9
Item
eclampsia, epilepsy, encephalopathy and history of mental disease or family;
boolean
C0004936 (UMLS CUI [1,1])
C0013537 (UMLS CUI [1,2])
C0014544 (UMLS CUI [1,3])
C0085584 (UMLS CUI [1,4])
C0013537 (UMLS CUI [1,2])
C0014544 (UMLS CUI [1,3])
C0085584 (UMLS CUI [1,4])
ID.10
Item
thrombocytopenia or other disturbance of blood coagulation which would lead to muscle injection taboo;
boolean
C0040034 (UMLS CUI [1,1])
C0005779 (UMLS CUI [1,2])
C0005779 (UMLS CUI [1,2])
ID.11
Item
fixed or suspected deficiency of immunologic function, containing immunosuppressant treatment(radiation therapy, chemical treatment, steroid hormone, antimetabolites, cytotoxic drugs), genetic defect(e.g. fabism), hiv or other factors;
boolean
C0021081 (UMLS CUI [1,1])
C0021051 (UMLS CUI [1,2])
C0021051 (UMLS CUI [1,2])
ID.12
Item
congenital malformation, eccyliosis or severe chronic disease(e.g. down syndrome, diabetes, sickle cell anemia or mental disease);
boolean
C0012634 (UMLS CUI [1])
ID.13
Item
fixed or suspected other disease including fever, active infection, liver and kidney disease, angiocardiopathy, malignancy, acute and chronic disease;
boolean
C0012634 (UMLS CUI [1])
ID.14
Item
joining other clinical study undergoing;
boolean
C0008976 (UMLS CUI [1])
ID.15
Item
women pregnant or in lactation.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
ID.17
Item
severe allergy for dose 1 or 2;
boolean
C0020517 (UMLS CUI [1])
ID.18
Item
severe adverse reaction associated with last vaccination;
boolean
C0559546 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,2])